PTCH polymorphism is associated with the rate of increase in basal cell carcinoma numbers during follow-up: Preliminary data on the influence of an exon 12-exon 23 haplotype

Environmental and Molecular Mutagenesis

Volumn 44, Issue 5, 2004, Pages 469-476

  Strange, Richard C ^a   El Genidy, Noha ^a   Ramachandran, Sudarshan ^a,b   Lovatt, Tracy J ^a   Fryer, Anthony A ^a   Smith, Andrew G ^a   Lear, John T ^c   Ichii Jones, Fumiyo ^a   Jones, Peter W ^d   Hoban, Paul R ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^c HOPE HOSPITAL   (United Kingdom)

^d KEELE UNIVERSITY   (United Kingdom)

Author keywords

Basal cell carcinoma; BCC numbers; Haplotypes; Polymorphism; PTCH

Indexed keywords

PROTEIN PATCHED;

ADULT; AGED; ALLELE; ARTICLE; BASAL CELL CARCINOMA; CANCER LOCALIZATION; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; EXON; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEAD AND NECK CANCER; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PARAMETER; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCORING SYSTEM; SUN EXPOSURE; SUNBURN; ULTRAVIOLET IRRADIATION;

ADULT; CARCINOMA, BASAL CELL; EXONS; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 19944430151     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20068     Document Type: Article

References (38)

1. Armstrong BK, Kricker A. 2001. The epidemiology of UV induced skin cancer. J Photochem Photobiol 63:8-18.
2. Aszterbaum M, Epstein J, Oro A, Douglas V, Leboit PE, Scott MP, Epstein E. 1999. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice. Nat Med 5:1285-1291.
3. Bastiaens MT, Hoefnagel JJ, Bruijn JA, Westendorp RG, Vermeer BJ, Bouwes Bavinck JN. 1998. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermal 110:880-884.
4. Bodak N, Queille S, Avril MF, Bouadjar B, Drougard C, Sarasin A, Grosjean LD. 1999. High levels of patched gene mutation in BCC from patients with XP. Proc Natl Acad Sci USA 96:5117-5122.
5. Bodiwala D, Luscombe CJ, French ME, Liu S, Saxby MF, Jones PW, Ramachandran S, Fryer AA, Strange RC. 2003. Susceptibility to prostate cancer: studies on interactions between UVR exposure and skin type. Carcinogenesis 24:711-717.
6. Bonifa JM, Pennypacker S, Chuang PT, McMahon AP, Williams M, Rosnthal A, de Sauvage FJ, Epstein EH. 2001. Activation of expression of Hedgehog target genes in basal cell carcinomas. J Invest Dermatol 116:739-742.
7. Cartegni L, Chew SL, Krainer AR. 2002. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Genet 3:285-298.
8. 1315Leu (C3944T) may modulate the association between use of oral contraceptives and breast cancer risk. Int J Cancer 103:779-783.
9. Colhoun HM, McKeigue PM, Smith GD. 2003. Problems of reporting genetic associations with complex outcomes. Lancet 361:865-872.
10. Czarnecki D, Mar A, Kulinskaya E. 1996. Cell-mediated immunity of patients who have had basal cell carcinomas. Acta Derm Venereol 76:28-30.
11. Deng JS, Falo LD, Kim B, Abell E. 1998. Cytotoxic T cells in basal cell carcinomas of skin. Am J Dermatopathol 20:143-146.
12. Dong J, Gailani MR, Pomeroy SL, Reardon D, Bale AE. 2000. Identification of PATCHED mutations in medulloblastomas by direct sequencing. Hum Mutat 16:89-90.
13. Fitzpatrick TB. 1988. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124:869-871.
14. Gailani MR, Stahle-Backdahl Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, Unden AB, Dean M, Brash DE, Bale AE, Toftgard R. 1996. The role of the human homologue of drosophila patched in sporadic basal cell carcinomas. Nat Genet 14:79-81.
15. Hahn H, Wicking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE. 1996. Mutations of the human homologue of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841-851.
16. Hoban PR, Ramachandran S, Strange RC. 2002. Environment, phenotype and genetics: risk factors associated with BCC of the skin. Exp Rev Anticancer Ther 2:570-579.
17. Hoy WE. 1996. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider. Cancer 77: 2489-2495.
18. Iftner A, Klug SJ, Garbe C, Blum A, Staneu A, Wilczynski SP, Iftner T. 2003. The prevalence of human papillomavirus genotypes in non-melanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res 63:7515-7519.
19. Jones PW, Strange RC, Ramachandran S, Fryer AA. 2002. Models for determining genetic susceptibility and predicting outcome. Methods Mol Biol 184:131-142.
20. Kennedy C, Bajdik CD, Willemze R, de Gruijl FR, Bouwes Bavinck JN. 2003. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 120:1087-1093.
21. Kricker A, Armstrong BK, English DR, Heenan PJ. 1995. Does intermittent sun exposure cause basal cell carcinoma? a case-control study in western Australia. Int J Cancer 60:489-494.
22. Lear IT, Smith A, Bowers B, Heagerty AHM, Jones PW, Gilford J, Alldersea J, Strange RC, Fryer AA. 1997. Tumor site in cutaneous basal cell carcinoma: Influence of glutathione S-transferase, GSTT1 and cytochrome P450, CYP1A1 genotypes and their interaction. J Invest Dermatol 108:519-522.
23. Luscombe CJ, Fryer AA, French ME, Liu S, Saxby MF, Jones PW, Strange RC. 2001. Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 358:641-642.
24. McCormack CJ, Kelly JW, Dorevitch AP. 1997. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. Arch Dermatol 133:593-596.
25. Nielsen DM, Ehm MG, Weir BS. 1999. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet 63:1531-1540.
26. Ramachandran S, Fryer AA, Smith AG, Lear JT, Bowers B, Griffiths CEM, Jones PW, Strange RC. 2000. Basal cell carcinoma: tumor clustering is associated with increased accrual in high-risk subgroups. Cancer 89:1012-1018.
27. Ramachandran S, Fryer AA, Lovatt T, Lear JT, Smith AG, Strange RC. 2001a. Susceptibility and modifier genes in cutaneous basal cell carcinomas and their associations with clinical phenotype. J Photochem Photobiol 63:1-7.
28. Ramachandran S, Fryer AA, Smith AG, Lear JT, Bowers B, Jones PW, Strange RC. 2001b. Cutaneous basal cell carcinomas: distinct host factors are associated with the development of tumors on the trunk and on the head and neck. Cancer 92:354-358.
29. Ramachandran S, Fryer AA, Lovatt T, Smith A, Lear J, Jones PW, Strange RC. 2002. The rate of increase in the numbers of primary sporadic basal cell carcinomas during follow-up is associated with age at first presentation. Carcinogenesis 23:2051-2054.
30. Ramachandran S, Fryer AA, Lovatt TJ, Smith AG, Lear JT, Jones PW, Strange RC. 2003. Combined effects of gender, skin type and polymorphic genes on clinical phenotype: use of rate of increase in numbers of basal cell carcinomas as a model system. Cancer Lett 189:175-181.
31. Richards FM, Goudie DR, Cooper WN, Jene Q, Barroso I, Wicking W, Wainwright BJ, Ferguson-Smith MA. 1997. Mapping the multiple self-healing squamous epithelioma (MSSE) gene and investigation of xeroderma pigmentosum group A (XPA) and PATCHED (PTCH) as candidate genes. Hum Genet 101:317-322.
32. Rosenberger WF. 1996. Dealing with multiplicities in pharmaco- epidemiologic studies. Pharmacoepidemiol Drug Safety 5:95-100.
33. Scrivener Y, Grosshans E, Cribier B. 2002. Variations of basal cell carcinomas according to gender, location and histopathological subtype. Br J Dermatol 147:41-47.
34. + T cells. J Immunol 169:5451-5457.
35. Wacholder S, Chanock S, Garcia-Closas M, El ghormli L, Rothman N. 2004. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Nat Cancer Inst 96:434-442.
36. Wicking C, Shanley S, Smythe I, Gilles S, Negus K, Graham S, Suthers G, Haites N, Edwards M, Wainwright B, Chenevix-Trench G. 1997. Most germ line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein and no genotype-phenotype correlations are evident. Am J Hum Genet 60:21-26.
37. Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G. 1997. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 57:2581-2585.
38. Wong C, Strange RC, Lear JT. 2003. Basal cell carcinoma. Br Med J 327:794-798.